The document discusses fructose and galactose metabolism, including how fructose must be phosphorylated by fructokinase before entering metabolic pathways. It also describes disorders that can occur due to deficiencies in enzymes involved in fructose or galactose metabolism, such as hereditary fructose intolerance. Additionally, the roles of sorbitol and galactose in metabolism are covered, as well as disorders related to the sorbitol pathway and galactose metabolism.
Under normal dietary intake the majority of the ingested fructose is metabolized by the enterocytes of the small intestine primarily to glucose which is then delivered to the systemic circulation. In addition to glucose, the carbon atoms from dietary fructose are converted, by intestinal enterocytes, into several other metabolites including glycerate, glutamate, glutamine, alanine, ornithine, and citrulline.
However, diets containing large amounts of sucrose, high fructose corn syrup, or fructose alone, overwhelm the ability of the small intestine to metabolize it all and under these conditions a significant amount of fructose is then metabolized by the liver and to a lesser extent by other organs such as skeletal muscle.
Gluconeogenesis- Steps, Regulation and clinical significanceNamrata Chhabra
Gluconeogenesis- Thermodynamic barriers, substrates of gluconeogenesis, reciprocal regulation of glycolysis and gluconeogenesis, biological and clinical significance
The glucuronic acid pathway is a quantitatively minor route of glucose metabolism. Like the pentose phosphate pathway, it provides biosynthetic precursors and inter-converts some less common sugars to ones that can be metabolized.
Under normal dietary intake the majority of the ingested fructose is metabolized by the enterocytes of the small intestine primarily to glucose which is then delivered to the systemic circulation. In addition to glucose, the carbon atoms from dietary fructose are converted, by intestinal enterocytes, into several other metabolites including glycerate, glutamate, glutamine, alanine, ornithine, and citrulline.
However, diets containing large amounts of sucrose, high fructose corn syrup, or fructose alone, overwhelm the ability of the small intestine to metabolize it all and under these conditions a significant amount of fructose is then metabolized by the liver and to a lesser extent by other organs such as skeletal muscle.
Gluconeogenesis- Steps, Regulation and clinical significanceNamrata Chhabra
Gluconeogenesis- Thermodynamic barriers, substrates of gluconeogenesis, reciprocal regulation of glycolysis and gluconeogenesis, biological and clinical significance
The glucuronic acid pathway is a quantitatively minor route of glucose metabolism. Like the pentose phosphate pathway, it provides biosynthetic precursors and inter-converts some less common sugars to ones that can be metabolized.
Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose across the plasma membrane, a process known as facilitated diffusion. Because glucose is a vital source of energy for all life, these transporters are present in all phyla.
carbohydrate metabolism, Glycolysis, metabolic process of carbohydrates, EMP ...RajkumarKumawat11
carbohydrate metabolism, Glycolysis, metabolic process of carbohydrates, EMP pathway, Embden- Meyerof-Paranas pathway, cabohydrate metabolic process for study, A presentation on cabohydrate metabolic process i.e. Glycolysis
Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose across the plasma membrane, a process known as facilitated diffusion. Because glucose is a vital source of energy for all life, these transporters are present in all phyla.
carbohydrate metabolism, Glycolysis, metabolic process of carbohydrates, EMP ...RajkumarKumawat11
carbohydrate metabolism, Glycolysis, metabolic process of carbohydrates, EMP pathway, Embden- Meyerof-Paranas pathway, cabohydrate metabolic process for study, A presentation on cabohydrate metabolic process i.e. Glycolysis
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. Fructose metabolism
Glucose is the most common
monosaccharide consumed
by humans,
and its metabolism has been
discussed extensively.
However, two other
monosaccharides—fructose
and galactose—occur in
significant amounts
in the diet (primarily in
disaccharides), and make
important contributions
to energy metabolism. In
addition, galactose is an
important component
of cell structural
carbohydrates
3. Phosphorylation of fructose
▪ For fructose to enter the pathways of intermediary
metabolism, itmust first be phosphorylated . This can be
accomplishedby either hexokinase or fructokinase (also
called ketohexo kinase).
▪ Hexokinase phosphorylates glucose in most cells of the
body, and several additional hexoses can serve as
substrates for this enzyme. However, it has a low affinity
(that is, a high Km, see for fructose. Therefore, unless the
intracellular concentration of
▪ fructose becomes unusually high, the normal presence of
saturatingconcentrations of glucose means that little
fructose is converted tofructose 6-phosphate by
hexokinase. Fructokinase provides the primaryfound in the
liver (which processes most of the dietary fructose),
kidney,
▪ and the small intestinal mucosa, and converts fructose to
fructose
▪ 1-phosphate, using ATP as the phosphate donor.
4. Cleavage of fructose- 1 phosphate
▪ aldolase B (also called fructose 1-phosphate
aldolase) todihydroxy acetone phosphate
(DHAP) and glyceraldehyde.
▪ [Note:Humans express three aldolases, A, B
and C, the products of threedifferent genes.
Aldolase A (found in most tissues), aldolase
B (in liver), and aldolase C (in brain) all cleave
fructose 1,6-bisphosphateproduced during
glycolysis to DHAP and glyceraldehyde 3-
phosphate
▪ , but only aldolase B cleaves fructose 1-
phosphate.]
6. Synthesis of fructose via sorbitol
▪ Most sugars are rapidly phosphorylated following their entry
into cells. They are thereby trapped within the cells, because
organ phosphates cannot freely cross membranes without
specific transporter An alternate mechanism for metabolizing
a monosaccharide is to convert it to a polyol (sugar alcohol) by
the reduction of an aldehyde group, thereby producing an
additional hydroxyl group.
▪ 1. Synthesis of sorbitol:
▪ Aldose reductase reduces glucose, producing sorbitol This
enzyme is found in many tissues, including the lens, retina,
Schwann cells of peripheral nerves, liver, kidney, placenta, red
blood cells, and in cells of the ovaries and seminal vesicles. In
cells of the liver, ovaries, and seminal vesicles,
▪ there is a second enzyme, sorbitol dehydrogenase, which can
oxidize the sorbitol to produce fructose
▪ . The two-reaction pathway from glucose to fructose in the
seminal vesicles is for the benefit of sperm cells, which use
fructose as a major carbohydrate energy source.
7. Disorders of fructose metobolism
disorders
hereditory
fructosuria
essentialfructosur
ia
8. Disorders of fructose metobolism
▪ A deficiency of one of the key enzymes required for the entry
offructose into intermediary metabolic pathways can result in
either benign condition as a result of fructokinase deficiency
(essentiafructosuria), or a severe disturbance of liver and kidney
meas a result of aldolase B deficiency (hereditary fructose
intolerancHFI), which is estimated to occur in 1:20,000 live births
.
▪ Fructose 1-phosphate accumulates, resulting in a drop in the level
of inorganic phosphate (Pi) and, therefore, of ATP. ATP falls,
AMP rises. In the absence of Pi, AMP is degraded, causing
hyperuricemia . The decreased availability of hepatic ATP affects
gluconeogenesis (causing hypoglycemia with vomiting), and protein
synthesis (causing a decreasein blood clotting factors and other
essential proteins)
▪ Kidney function may also be affected. Diagnosis of HFI can be
made on the basis of fructose in the urine, enzyme assay or by
DNA-based testing
▪ With HFI, sucrose and sorbitol (a sugar alcohol),as well as
fructose, must be removed from the diet to prevent liver failure
9.
10. Disordes of sorbitol pathway
▪ Because insulin is not required for
the entry of glucose into the cells listed in the previous
paragraph, large amounts of glucose may enter these
cells during times of hyperglycemia, for example, in
uncontrolled diabetes. Elevated intracellular glucose
concentrations and an adequate supply of NADPH cause
aldose reductase to produce asignificant increase in the
amount of sorbitol, which cannot pass efficiently
through cell membranes and, therefore, remains
trappedinside the cell .
This is exacerbated when sorbitol dehydrogenase is low or
absent, for example, in retina, lens, kidney, and nerve cells.
As a result, sorbitol accumulates in these cells, causing
strong osmotic effects and, therefore, cell swelling as
▪ a result of water retention. Some of the pathologic
alterations associated with diabetes can be attributed,
in part, to this phenomenon ,including cataract
formation, peripheral neuropathy, and microvascular
problems leading to nephropathy and retinopathy
11. Galactose metabolism
▪ The major dietary source of galactose
is lactose (galactosyl β-1,4-
glucosidase obtained from milk and
milk products
▪ Some galactose can also be obtained
by lysosomal degradation of complex
carbohydrates, such as glycoproteins
and glycolipids, which are important
membrane components.
▪ Like fructose, the entry of galactose
into cells is not insulin-dependent.
12. ▪ A. Phosphorylation of galactose
▪ Like fructose, galactose must be phosphorylated
before it can be further metabolized. Most
tissues have a specific enzyme for this purpose,
galactokinase, which produces galactose 1-
phosphate As with other kinases, ATP is the
phosphate donor.
▪ B. Formation of UDP-galactose
▪ Galactose 1-phosphate cannot enter the glycolytic
pathway unless it is first converted to UDP-
galactose . This occurs in an exchange reaction, in
which UDP-glucose reacts with galactose1-
phosphate, producing UDP-galactose and glucose 1-
phosphate
13. Use of UDP-galactose as a carbon source
for glycolysis or gluconeogenesis
For UDP-galactose to enter the mainstream of glucose
metabolism, it must first be converted to its C-4 epimer, UDP-
glucose, by UDP hexose4-epimerase.
This “new” UDP-glucose (produced from the original UDP-
galactose) can then participate in many biosynthetic
Role of UDP-galactose in biosynthetic
reactions
UDP-galactose can serve as the donor of galactose units in a
number of synthetic pathways, including synthesis of lactose ,
glycoproteins , glycolipid, and glycosaminoglycans
If galactose is not provided by the diet (for example, when it
cannot be released from lactose as a result of a lack of β-
galactosidase in people who are lactose-intolerant), All tissue
requirements for UDP-galactose can be met by the action of
UDP-hexose 4-epimerase on UDP-glucose, which is efficiently
produced from glucose 1-phosphate
16. GALACTOKINASE
DEFICIENCY
▪ Rare autosomal recessive
disorder
▪ Causes elevation of galactose
in blood (galactosemia) and
urine (galactosuria)
▪ Causes galactitol accumulation
if galactose is present in the
diet.
▪ Elevated galactitol can cause
17. Classical galactosemia
▪ Galactose 1-phosphate uridyltransferase (GALT)
deficiency.
▪ Autosomal recessive disorder (1:30,000 births).
▪ Causes galactosemia and galactosuria, vomiting,diarrhea,
and jaundice.
▪ • Accumulation of galactose 1-phosphate and galactitol
in nerve, lens, liver, and kidney tissue causes liver
damage, severe mental retardation, and cataracts.
▪ Prenatal diagnosis is possible by chorionic villus
sampling. Newborn screening is available.
▪ Therapy: Rapid diagnosis and removal ofgalactose (and
therefore lactose) from the diet.
▪ Despite adequate treatment, at risk for
18.
19. Some brainy challenges
Following the intravenous injection of lactose into a
rat, none of the lactose is metabolized. However,
ingestion of lactose leads to rapid metabolism of this
disaccharide.The difference in these observations is
a result of:
A. the presence of lactase in the serum.
B. the absence of hepatic galactokinase.
C.the absence of maltase in the serum.
D.the presence of lactase in the intestine.
20. answer
correct answer = D
. Lactase and maltase are
intestinal enzymes not found in the serum.
Therefore, ingested lactose is degraded, but
injected lactose is not. If hepatic galactokinase
is absent, the galactose segment of the lactose
is not metabolized, but the glucose segment of
the lactose can still be metabolized.
21. female with classic galactosemia due to GALT
deficiency
is able to produce lactose in breast milk
because:
A. free (nonphosphorylated) galactose is the acceptor
of glucose transferred by lactose synthase in
the synthesis of lactose.
B. galactose can be produced from a glucose
metabolite by epimerization.
C. hexokinase can efficiently phosphorylate dietary
galactose to galactose 1-phosphate
D. the enzyme deficient in galactosemia is activated
by a hormone produced in the mammary gland.
E. galactose can be produced from fructose by isomerization
22. Correct answer = B.
UDP-hexose 4-epimerase
converts UDP-glucose to UDP-galactose, thus
providing the appropriate form of galactose for
lactose synthesis. UDP-galactose, not free
galactose, is the source of the galactose portion
of lactose. Galactose is not converted to galactose
1-phosphate by hexokinase. Galactosemia
is the result of a deficiency in GALT.
Isomerization of fructose to galactose does not
occur in the human body.
23. A 5-month-old boy is brought to his physician
because of vomiting, night sweats, and tremors.
History revealed that these symptoms began after
fruit juices were introduced to his diet as he was
being weaned off breast milk.The physical examination
was remarkable for hepatomegaly.Tests on the
baby’s urine were positive for reducing sugar but
negative for glucose.The infant most likely suffers
from:
A. aldolase B deficiency.
B. fructokinase deficiency.
C. galactokinase deficiency.
D. β-galactosidase deficiency.
E. glucose 6-phosphatase deficiency
24. Correct answer = A
.The symptoms suggest
fructose intolerance, a deficiency in aldolase B.
Deficiencies in fructokinase or galactokinase
result in relatively benign conditions characterized
by elevated levels of fructose or galactose
in the blood and urine. Deficiency in
β–galactosidase (lactase) results in a decreased
ability to degrade lactose (milk sugar).
Congenital lactase deficiency is quite rare and
would have presented much earlier in this baby,
and with different symptoms.Typical lactase
deficiency (adult hypolactasia) presents at a
later age.The symptoms of glucose 6-phosphatase
deficiency would result from fasting, and
would not be related to ingestion of fruit juice.